EXIT READINESS SIGNALS FRAMEWORK

Is the growth you’re investing in today strengthening your future exit… or quietly weakening it?

Download the Exit Readiness Signals Framework

Most mid-market healthcare companies lose leverage in dilligence because their growth sends the wrong signals.

Download our guide for healthcare CEOs who want to maximize enterprise value before an upcoming transaction.

Get the framework

Enter your details to download the Exit Readiness Signals Framework instantly.

Oops! Something went wrong while submitting the form..
‍
We respect your inbox. No spam. Executive-level insights only.
Private equity investment committees and strategic acquirers are not only asking, “Did you grow?”

They’re asking:
Is the growth repeatable?
Is it defensible?
Can it run without the founder?
Does the story hold up under scrutiny?
This framework shows you how buyers actually evaluate growth during diligence and where valuation risk hides in plain sight.
Dashboard mockup

Growth alone doesn’t command a premium multiple.

Strong revenue and EBITDA do not automatically translate into strong evaluation.
Growth that is:
hard to explain
operationally messy
overly founder-dependent
artificially propped up
strategically unfocused
…creates buyer hesitation. And hesitation reduces the competitive tension that compounds multiples.

In today’s market, clarity is leverage. Ambiguity is a discount. This framework was built to help you pressure-test your company before buyers do.
Download the Exit Readiness Signals Framework
WHAT OUR CLIENTS SAY
“Before the Exit Readiness Sprint, I didn't have an appreciation for what a successful external engagement could bring to the business. The work that Legacy DNA has done over the last 3 months will drive more value than I was ever expecting going into the engagement. I will make the decision to use Legacy DNA time and time again regardless of where my career takes me.”
— Natasha Hennessy, CEO of Apotheco Medicinals

What buyers actually evaluate

Inside this white paper, you’ll learn the five signals sophisticated buyers evaluate during diligence:
  • Narrative Signal - Can the growth story be explained clearly and consistently?
  • Growth Quality Signal - Is growth durable or artificially propped up?
  • Operational Signal - Does growth reduce friction or add complexity?
  • Leadership Signal - Can the business run without the founder in every decision?
  • Market Signal - Are you investing in value creation or value distraction?
Through a diligence lens, we unpack each signal to help you better understand:
  • What buyers look for
  • Red flags that trigger valuation discounts
  • Positive indicators that increase confidence
This framework is designed to be used as a pause buttonbefore momentum turns into a mess. It reflects how buyers actually evaluate growthin healthcare, pharmacy, and health-tech companies.

About Legacy DNA

Legacy DNA is a commercialization and valuation partner to mid-market healthcare companies.

We’ve supported four successful exits and work alongside founders, boards, and PE operators to clarify positioning, strengthen growth systems, and reduce valuation risk. We specialize in healthtech, pharmacy, women’s health, longevity, and agetech.

Growth should increase enterprise value, not just revenue.

Download the Exit Readiness Signals Framework